tiprankstipranks
Immutep Ltd (PRRUF)
OTHER OTC:PRRUF
US Market

Immutep Ltd (PRRUF) Stock News & Sentiment

25 Followers
Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline
Premium
Company Announcements
Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline
7d ago
Insignia Financial Ceases to Be Substantial Holder in Immutep
Premium
Company Announcements
Insignia Financial Ceases to Be Substantial Holder in Immutep
27d ago
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
Premium
Company Announcements
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
27d ago
UBS Group Ceases to Be Substantial Shareholder in Immutep
Premium
Company Announcements
UBS Group Ceases to Be Substantial Shareholder in Immutep
27d ago
Immutep Trading Resumes on ASX After Key Phase III Trial Update
Premium
Company Announcements
Immutep Trading Resumes on ASX After Key Phase III Trial Update
1M ago
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
Premium
Company Announcements
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
1M ago
Immutep Shares Suspended Pending Key Phase III Trial Futility Update
Premium
Company Announcements
Immutep Shares Suspended Pending Key Phase III Trial Futility Update
1M ago
More PRRUF News >

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PRRUF’s Media Buzz Sentiment?
Currently, no data Available
What is PRRUF’s weekly average amount of articles?
Currently, no data Available
What is PRRUF’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
ALLOAllogene Therapeutics
STAAStaar Surgical
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week